Laekna, Inc. (HKG:2105)
Hong Kong · Delayed Price · Currency is HKD 5.66
-0.55 (-8.79%)
Oct 22, 2026, 3:40 PM HKT
Laekna Market Cap
Laekna has a market cap or net worth of 2.41 billion as of October 21, 2026. It is the 17,715th most valuable company in the world and the 780th biggest in Hong Kong. Its market cap has decreased by 59.11% in one year.
Market Cap
2.41B
Enterprise Value
1.29B
Revenue
296.69M
Global Rank
Country Rank
#780 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since June 29, 2023, Laekna's market cap has decreased from 5.85B to 2.41B, a decrease of -58.82%. That is a compound annual growth rate of -23.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 2.41B | -57.54% |
| Dec 31, 2025 | 5.68B | 62.12% |
| Dec 31, 2024 | 3.50B | -54.90% |
| Dec 29, 2023 | 7.76B | 32.67% |
| Jun 29, 2023 | 5.85B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hanx Biopharmaceuticals (Wuhan) | 3.58B |
| Beijing Luzhu Biotechnology | 3.04B |
| Frontage Holdings | 3.03B |
| Shanghai Bao Pharmaceuticals | 2.97B |
| Viva Biotech Holdings | 2.80B |
| Medtide | 2.80B |
| BioDlink International Company | 2.70B |
| HJ Science | 2.57B |